A detailed history of Fragasso Group Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Fragasso Group Inc. holds 15,025 shares of CRL stock, worth $2.8 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
15,025
Previous 16,465 8.75%
Holding current value
$2.8 Million
Previous $3.4 Million 13.0%
% of portfolio
0.24%
Previous 0.29%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$187.96 - $245.29 $270,662 - $353,217
-1,440 Reduced 8.75%
15,025 $2.96 Million
Q2 2024

Jul 08, 2024

SELL
$206.39 - $268.73 $1.97 Million - $2.56 Million
-9,524 Reduced 36.65%
16,465 $3.4 Million
Q1 2024

Apr 10, 2024

SELL
$203.52 - $273.43 $165,258 - $222,025
-812 Reduced 3.03%
25,989 $7.04 Million
Q4 2023

Jan 08, 2024

BUY
$164.52 - $238.84 $466,578 - $677,350
2,836 Added 11.83%
26,801 $6.34 Million
Q3 2023

Dec 06, 2023

BUY
$194.44 - $217.61 $51,526 - $57,666
265 Added 1.12%
23,965 $4.7 Million
Q2 2023

Jul 10, 2023

BUY
$183.71 - $210.25 $190,507 - $218,029
1,037 Added 4.58%
23,700 $4.98 Million
Q1 2023

Apr 13, 2023

BUY
$191.89 - $259.92 $90,380 - $122,422
471 Added 2.12%
22,663 $4.57 Million
Q4 2022

Jan 24, 2023

SELL
$197.11 - $250.07 $4.37 Million - $5.55 Million
-22,192 Closed
0 $0
Q4 2022

Jan 24, 2023

BUY
$197.11 - $250.07 $253,680 - $321,840
1,287 Added 6.16%
22,192 $0
Q3 2022

Oct 13, 2022

SELL
$182.44 - $250.54 $49,988 - $68,647
-274 Reduced 1.29%
20,905 $4.11 Million
Q2 2022

Aug 30, 2022

BUY
$204.13 - $302.4 $180,859 - $267,926
886 Added 4.37%
21,179 $4.53 Million
Q1 2022

Apr 06, 2022

SELL
$255.51 - $362.11 $249,377 - $353,419
-976 Reduced 4.59%
20,293 $5.76 Million
Q4 2021

Jan 19, 2022

SELL
$351.38 - $448.68 $444,847 - $568,028
-1,266 Reduced 5.62%
21,269 $8.01 Million
Q3 2021

Oct 08, 2021

SELL
$372.64 - $458.3 $71,546 - $87,993
-192 Reduced 0.84%
22,535 $9.3 Million
Q2 2021

Jul 19, 2021

SELL
$294.17 - $371.65 $39,418 - $49,801
-134 Reduced 0.59%
22,727 $8.41 Million
Q1 2021

May 27, 2021

BUY
$249.67 - $299.48 $66,911 - $80,260
268 Added 1.19%
22,861 $6.63 Million
Q4 2020

Feb 04, 2021

SELL
$222.0 - $252.62 $278,832 - $317,290
-1,256 Reduced 5.27%
22,593 $5.65 Million
Q3 2020

Nov 05, 2020

BUY
$175.56 - $226.45 $9,304 - $12,001
53 Added 0.22%
23,849 $5.4 Million
Q2 2020

Aug 10, 2020

SELL
$118.84 - $189.72 $254,317 - $406,000
-2,140 Reduced 8.25%
23,796 $5.27 Million
Q1 2020

May 14, 2020

BUY
$98.9 - $178.34 $29,768 - $53,680
301 Added 1.17%
25,936 $3.27 Million
Q4 2019

Feb 13, 2020

BUY
$126.05 - $152.76 $67,562 - $81,879
536 Added 2.14%
25,635 $3.92 Million
Q3 2019

Nov 13, 2019

SELL
$125.07 - $143.67 $13,507 - $15,516
-108 Reduced 0.43%
25,099 $3.32 Million
Q2 2019

Aug 13, 2019

BUY
$123.4 - $148.55 $3.11 Million - $3.74 Million
25,207 New
25,207 $3.58 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.48B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Fragasso Group Inc. Portfolio

Follow Fragasso Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fragasso Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fragasso Group Inc. with notifications on news.